Although we did not evaluate if impairing the glycolytic flux induces a switch toward OXPHOS in BRAF-mutated tumour cells, our results encouraged us to exploit energy metabolism as an additional process to target together with the MAPK pathway. This evidence concerns the gene BRAF and neoplasm.